Merck Gets Positive CHMP Opinion For Keytruda Plus Chemotherapy For Triple-Negative Breast Cancer
17/9 15:06
(RTTNews) - Merck & Co., Inc. (MRK) said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of KEYTRUDA, Merck's anti-PD-1 therapy, in combination with chemotherapy for the treatment of locally recurrent...